The times at which new drugs were licensed since 1960 have been compared for Sweden and five other countries, and the differences in licensing time between these countries have been evaluated statistically. Also, the time required for the Swedish authorities to process the licence applications has been studied and compared with the small number of similar studies available from other countries. A relationship between the delay in licensing and the processing time is discussed.
No takes yet. Share an insight, caveat, or question.
Berlin et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: